Abstract
Aberrant innate and adaptive immune responses are neurodegenerative disease effectors. Disease is heralded by a generalized, but subtle immune activation orchestrated by the release of extracellular prion-like aggregated and oxidized or otherwise modified proteins. These are responsible for an inflammatory neurotoxic cascade. The perpetrators of such events include effector T cells and activated microglia. What ensues are Alzheimer’s and Parkinson’s disease, amyotrophic lateral sclerosis and stroke with changed frequencies of effector T cell and reduced numbers or function of regulatory lymphocytes. The control of such immune responses could lead to new therapeutic strategies and the means to effectively combat a composite of diseases that have quite limited therapeutic options.
Original language | English (US) |
---|---|
Pages (from-to) | 645-650 |
Number of pages | 6 |
Journal | Journal of Neuroimmune Pharmacology |
Volume | 10 |
Issue number | 4 |
DOIs | |
State | Published - Dec 1 2015 |
Keywords
- Adaptive immunity
- Alzheimer’s disease
- Amyotrophic lateral sclerosis
- Effector T cells
- Innate immunity
- Neurodegenerative diseases
- Neurodestruction
- Neuroprotection
- Parkinson’s disease
- Regulatory T cells
- Stroke
ASJC Scopus subject areas
- Neuroscience (miscellaneous)
- Immunology and Allergy
- Immunology
- Pharmacology